Evidence map›Paper›PMID 42088329›Full record

ArticleStroke (Hoboken, N.J.)2026

Diagnostic Accuracy of Lateral Flow Blood Tests to Detect Large Vessel Occlusion Stroke.

Lisa Shaw, Rachel Binks, David Burgess, Anand Dixit, Edoardo Gaude, Clare Lendrem, Graham McClelland, Philip White, Gewei Zhu, Christopher I Price

Abstract read
In one paragraph

Article in Stroke (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lisa ShawStroke Research Group, Population Health Sciences Institute (L.S., G.Z., C.I.P.), Newcastle University, United Kingdom.ORCID https://orcid.org/0000-0002-3435-9519
Rachel BinksNational Institute for Health and Care Research (NIHR) HealthTech Research Centre in Diagnostic and Technology Evaluation, Newcastle University and Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust, United Kingdom (R.B., C.L.).ORCID https://orcid.org/0009-0002-5258-5963
David BurgessStroke Research Group, Population Health Sciences Institute (L.S., G.Z., C.I.P.), Newcastle University, United Kingdom.
Anand DixitNewcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, United Kingdom (A.D.).ORCID https://orcid.org/0009-0009-4525-1560
Edoardo GaudePockit Diagnostics Ltd trading as Upfront Diagnostics, CR UK Cambridge Institute, United Kingdom (E.G.).ORCID https://orcid.org/0000-0001-8523-7792
Clare LendremNational Institute for Health and Care Research (NIHR) HealthTech Research Centre in Diagnostic and Technology Evaluation, Newcastle University and Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust, United Kingdom (R.B., C.L.).ORCID https://orcid.org/0000-0002-9435-7398
Graham McClellandDepartment of Nursing, Midwifery and Health, Faculty of Health and Life Science, Northumbria University, Newcastle upon Tyne, United Kingdom (G.M.).ORCID https://orcid.org/0000-0002-4502-5821
Philip WhiteTranslational and Clinical Research Institute (P.W.), Newcastle University, United Kingdom.ORCID https://orcid.org/0000-0001-6007-6013
Gewei ZhuStroke Research Group, Population Health Sciences Institute (L.S., G.Z., C.I.P.), Newcastle University, United Kingdom.ORCID https://orcid.org/0000-0002-8951-7924
Christopher I PriceStroke Research Group, Population Health Sciences Institute (L.S., G.Z., C.I.P.), Newcastle University, United Kingdom.ORCID https://orcid.org/0000-0003-3566-3157

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA rapid and accurate tool to identify large vessel occlusion stroke (LVO) for use by prehospital emergency medical services responders could support direct access to time-critical thrombectomy at regional Comprehensive Stroke Centers. This study evaluated the accuracy of D-dimer and GFAP (glial fibrillary acidic protein) detected by lateral flow tests (LFT) to identify LVO stroke.

methodsThis hospital-based prospective observational cohort study recruited adults within 6 hours of onset of at least 1 face, arm, or speech test (FAST) symptom. The LFTs use fingerprick capillary blood and give an overall positive (ie, LVO stroke predicted) or negative LFT outcome. Independent adjudication of brain imaging and clinical data established LVO or non-LVO. Specificity, sensitivity, negative and positive predictive values were calculated for (1) LFT outcome for participants with >1 FAST symptoms (primary analysis population); (2) a combined decision rule where participants with 1 FAST symptom were rule negative, patients with >1 FAST symptoms rule positive or negative according to LFT outcome; (3) FAST symptoms alone split by 1 symptom versus >1 symptom.

resultsThe study involved 382 participants (age [mean], 72.4 years; female, 50.8%; National Institutes of Health Stroke Scale score [median], 6; time from onset to LFT [median], 130 minutes). Of 278 participants who met the primary analysis population, 202 of 278 had both LFT outcome and LVO/non-LVO assigned. Analysis gave specificity 79% (95% CI, 72%-85%), sensitivity 53% (95% CI, 39%-67%), negative predictive value 86% (95% CI, 79%-90%), and positive predictive value 42% (95% CI, 30%-55%). For 382 participants with 1 to 3 FAST symptoms, 290 of 382 had both a combined decision rule result and LVO/non-LVO assigned giving specificity 86% (95% CI, 82%-90%), sensitivity 51% (95% CI, 37%-65%), negative predictive value 90% (95% CI, 86%-93%), positive predictive value 42% (95% CI, 30%-55%). FAST symptoms alone (n=318) gave specificity 33% (95% CI, 27%-38%), sensitivity 96% (95% CI, 87%-99%), negative predictive value 98% (95% CI, 92%-99%), positive predictive value 23% (95% CI, 18%-29%).

conclusionsLFT outcome combined with FAST symptoms gave high specificity for LVO identification. This approach could be considered for facilitation of direct access to thrombectomy providers. However, further research is required to evaluate test performance in the prehospital setting and consider technological improvements to boost sensitivity without compromising specificity. REGISTRATION: URL: https://www.isrctn.com/; Unique identifier: ISRCTN12414986.

Indexed as

biomarkersemergency medical servicesglial fibrillary acidic proteinstrokethrombectomy

Identifiers

PMID42088329
PMCPMC13138473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.